Archives

by in
Entry Author Date Location
Five Reasons Illumina Should Fight Roche’s Insulting Low-Ball Bid 03/05/12 National
SD Life Sciences Roundup: Illumina, Applied Proteomics, & Tocagen 02/10/12 San Diego
Four Themes to Watch in Personalized Medicine 01/30/12 San Francisco
San Diego Life Sciences Roundup: Illumina, Sequenom, Acutus, & More 01/26/12 San Diego
Roche Makes $5.7B Hostile Takeover Bid for Illumina 01/25/12 San Diego
Affymax Prepares to Mount Challenge to Amgen Anemia Drug Monopoly 01/25/12 San Francisco
Alnylam Cuts One-Third of Workforce, To Save Cash for RNAi Clinical Plans 01/19/12 Boston
Onyx, Bayer’s Next Cancer Drug Shows Slim Survival Edge 01/17/12 San Francisco
Genentech Pours $95M Into Constellation’s Drug Platform 01/17/12 Boston
San Diego Life Sciences Roundup: Isis, Elevation, Proacta, and More 01/06/12 San Diego
Alnylam Gets First Hint of Effectiveness for RNAi Cholesterol-Lowering Drug 01/04/12 Boston
Millennium: Takeda Acquires San Diego’s Intellikine for $190M Upfront 12/20/11 Boston
The Hepatitis C Market: Biotech’s Version of the Daytona 500 12/12/11 National
Genentech’s Two-Drug Strategy Raises the Bar in Breast Cancer 12/07/11 San Francisco
Seattle Genetics Sees Case of PML, Causing Market Twitch 12/01/11 Seattle
Regeneron Debuts Eye Drug, as Rivals Race to Grab Share of Hot Market 12/01/11 New York
Genentech Looks to Turn the Page at Breast Cancer Confab 12/01/11 San Francisco
Roche Embraces Three-Way Rare-Disease Play With PTC and Patient Group 11/30/11 New York
Aileron Expands Roche Deal, Agios Gets $78M, Genzyme MS Drug Advances, & More Boston-Area Life Sciences News 11/18/11 Boston
Aileron CEO Hails Expanded Roche Deal as a Validation of Stapled-Peptide Drug Technology 11/17/11 Boston
Xconomists of the Week: Tom Maniatis and Marc Tessier-Lavigne Lead the Charge on the New York Genome Center 11/03/11 New York
The Cancer Drug Dark Ages Are Coming to an End 10/31/11 National
Roche Acquires Anadys, Wests Create $100M Fund, Johnson & Johnson Makes Room for 20 Startups, & More San Diego Life Sciences News 10/20/11 San Diego
Anadys Pharmaceuticals Surprises the Street, Gets Acquired by Roche for $230M 10/17/11 San Diego
Join Us for a Live ‘Tweetchat’ on the Future of RNAi, With Guest John Maraganore of Alnylam 09/28/11 National
Genentech, ImmunoGen’s Souped-Up Antibody for Breast Cancer Passes Key Test 09/24/11 San Francisco
New York Life Sciences 2031: OrbiMed’s Sam Isaly on Genomics, Health Reform, and Biotech’s Future 09/22/11 New York
Stirring the Pot Once in a While Doesn’t Hurt, and It Could Help Biotech Break its Malaise 09/19/11 National
Merck Joins the Big Pharma VC Party, Setting Up $250M Biotech Investment Fund 09/15/11 National
Ion Torrent’s Fast and Cheap DNA Sequencer Catches On, Even as Biologists Tighten Belts 09/15/11 National
Page 3 of 12 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  2. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Zillions of Biotech Conferences Want You. Which Should You Attend?
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.